Albert David Limited (NSE:ALBERTDAVD)

Market Cap	5.25B
Revenue (ttm)	3.46B
Net Income (ttm)	172.01M
Shares Out	n/a
EPS (ttm)	30.14
PE Ratio	30.55
Forward PE	n/a
Dividend	5.00 (0.54%)
Ex-Dividend Date	Jul 25, 2025

Volume	1,372
Average Volume	9,279
Open	923.55
Previous Close	921.95
Day's Range	923.55 - 934.00
52-Week Range	762.60 - 1,753.95
Beta	0.04
RSI	67.41
Earnings Date	Aug 8, 2025

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1938
• Employees: 1,497
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALBERTDAVD

Financial Performance

In 2024, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.